Finance

Lists
CHM:ASX
Chimeric Therapeutics Ltd
A$0,0030
0,00%
(0,00) 1D
30 Sep., 17:11:03 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for CHM...
Mkt. cap
177,19 k
Avg. vol.
837,57 k
Volume
0,00
52-wk high
A$0,40
52-wk low
A$0,00
EPS
-A$0,61
Shares outstanding
147,46 m
Mkt. cap
177,19 k
Avg. vol.
837,57 k
Volume
0,00
52-wk high
A$0,40
52-wk low
A$0,00
EPS
-A$0,61
Shares outstanding
147,46 m
News stories
From web sources and news partners
About Chimeric Therapeutics Ltd
CEO-
Employees-
Founded2020
Headquarters-
SectorHealth Care
Industry-
Websitechimerictherapeutics.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,31 m
1,31 m
-1,40 m
-1,40 m
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
399,44 k
399,44 k
1,31 m
1,31 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,35 m
1,35 m
953,59 k
953,59 k
Operating expense
1,94 m
1,94 m
2,23 m
2,23 m
Total operating expenses
1,94 m
1,94 m
2,23 m
2,23 m
Operating income
-634,86 k
-634,86 k
-3,64 m
-3,64 m
Other non operating income
-
-
-8,94 k
-8,94 k
EBT including unusual items
-5,59 m
-5,59 m
-3,81 m
-3,81 m
EBT excluding unusual items
-709,86 k
-709,86 k
-3,55 m
-3,55 m
Income tax expense
21,60 k
21,60 k
-10,53 k
-10,53 k
Effective tax rate
-0,39%
-0,39%
0,28%
0,28%
Other operating expenses
-
-
-
-
Net income
-5,61 m
-5,61 m
-3,80 m
-3,80 m
Net profit margin
-428,19%
-428,19%
270,30%
270,30%
Earnings per share
-
-
-
-
Interest and investment income
13,78 k
13,78 k
5,84 k
5,84 k
Interest expense
-88,79 k
-88,79 k
-55,19 k
-55,19 k
Net interest expenses
-75,01 k
-75,01 k
-49,35 k
-49,35 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-391,47 k
-391,47 k
-3,62 m
-3,62 m
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme